Enrichment of <i>HER2</i> Amplification in Brain Metastases from Primary Gastrointestinal Malignancies
Devarati Mitra(Brigham and Women's Hospital), Theodore S. Hong(Massachusetts General Hospital), Ryan B. Corcoran(Massachusetts General Hospital), Aparna R. Parikh(Massachusetts General Hospital), Helen A. Shih(Massachusetts General Hospital), A. John Iafrate(Massachusetts General Hospital), William T. Curry(Harvard University), Jochen K. Lennerz(Addgene), David P. Ryan(East Carolina University), Jennifer Y. Wo(Massachusetts General Hospital), Jeffrey W. Clark(Massachusetts General Hospital), Darrell R. Borger(Massachusetts Eye and Ear Infirmary), Priscilla K. Brastianos(Massachusetts General Hospital), Kevin Oh(Massachusetts General Hospital), Matthew R. Strickland(Massachusetts General Hospital)
Cited by 25
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
|Nature Medicine|2004|2k
Detection of Mutations in <i>EGFR</i> in Circulating Lung-Cancer Cells
|New England Journal of Medicine|2008|1.6k